IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,664,000 | -31.8% | 400,000 | 0.0% | 0.22% | -43.7% |
| Q4 2020 | $18,560,000 | +40.9% | 400,000 | 0.0% | 0.40% | +24.4% |
| Q3 2020 | $13,168,000 | -4.1% | 400,000 | -20.0% | 0.32% | -16.7% |
| Q2 2020 | $13,725,000 | -38.9% | 500,000 | -33.3% | 0.38% | -59.5% |
| Q1 2020 | $22,451,000 | +62.2% | 750,000 | +50.0% | 0.95% | +77.4% |
| Q4 2019 | $13,840,000 | +8.6% | 500,000 | -28.6% | 0.54% | +4.7% |
| Q3 2019 | $12,740,000 | -25.8% | 700,000 | 0.0% | 0.51% | -26.4% |
| Q2 2019 | $17,164,000 | +261.0% | 700,000 | +40.0% | 0.69% | +257.7% |
| Q1 2019 | $4,755,000 | +7.5% | 500,000 | 0.0% | 0.19% | +18.3% |
| Q4 2018 | $4,425,000 | -43.8% | 500,000 | -28.6% | 0.16% | -20.0% |
| Q3 2018 | $7,875,000 | -12.1% | 700,000 | 0.0% | 0.20% | +7.9% |
| Q2 2018 | $8,960,000 | +15.3% | 700,000 | +52.2% | 0.19% | +95.9% |
| Q1 2018 | $7,774,000 | – | 460,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |